Clinical Trial Update: Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS [Phase 2]

View source ↗

Summary

Phase II decentralized pragmatic trial evaluating adjuvant doxorubicin and trabectedin chemotherapy for uterine leiomyosarcoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Trabectedin (trabectedin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Uterine Leiomyosarcoma | Phase 2 | Status: RECRUITING